S I Cap. & Fin. (530907)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Book value per share of ₹8.91 gives some tangible asset support, though price is well above it.
• Positive ROE of 10.57% shows equity is being put to work, albeit modestly.
• Latest quarter sales of ₹1 Cr confirm the business is operational, not just a shell.
• The stock is ~21.8% above its 52-week low, suggesting some speculative excess has already been removed.

Concerns

• P/E of 43.80 with zero reported sales and profit growth implies an expensive valuation for a stagnant business.
• P/B of 3.31 against book value of ₹8.91 means investors pay a ₹20.59 per share premium for limited earnings power.
• Piotroski F-Score of 4/9 signals weak overall financial health and operating efficiency.
• Micro-cap status with no dividend and negligible quarterly profit creates liquidity and governance risks.

AI Analysis

When I look at S I Cap. & Fin., I do not see a compounder. The first screen I ask is: how much growth is the price buying? Here I pay ₹29.50 for a business whose latest quarter sales are just ₹1 Cr and net profit is effectively ₹0 Cr. The headline P/E of 43.80 and P/B of 3.31 are not cheap under any Graham measure. Book value is ₹8.91, so I am paying more than three times tangible net worth for a business earning only 10.57% on equity and 8.26% on capital employed. That is a modest return, not a wonderful franchise. With zero sales growth, zero profit growth, no dividend yield, and a Piotroski F-score of only 4 out of 9, the financial health and operating momentum are weak. A PEG of 0.97 might seem reasonable, but it is meaningless when true reported profit growth is zero; it teases. The market cap of ₹13 Cr means this is a micro-cap in a diversified commercial services industry, with no obvious moat or scale advantages. I cannot identify a durable competitive position. The 52-week range shows it fell from ₹43 to ₹24.23; today's ₹29.50 is still far above book value. As Graham said, price is what you pay, value is what you get. At this price, I get low growth, tiny earnings, and no margin of safety. If the business is stable but stagnant, this is a slow grower at best, and the valuation gives me no comfort. I would rather wait for a much lower price closer to book value, or for evidence of real growth and improving returns on capital. Until then, this belongs on the pass list.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer